Leica Biosystems Aperio Digital Pathology Now Nationwide Standard of Care in Kuwait*

PR68675

VISTA, California, May 23 /PRNewswire=KYODO JBN/ --

Leica Biosystems announced today that it has struck a key partnership with the

Kuwait Ministry of Health, through its distributor, Technical Services Supplies

Trading & Contracting Company, W.L.L. The Pathology Council of Kuwait will now

adopt Leica Biosystems digital pathology as its standard of care. This

initiative will create a nationwide pathology network, powered by Aperio

ePathology Solutions (

http://www.leicabiosystems.com/digital-pathology/aperio-digital-pathology-slide-scanners/products/aperio-versa/),

linking eight key hospitals and leveraging pathology expertise across the

country.

     (Photo:

http://mma.prnewswire.com/media/515139/Leica_Biosystems_Aperio_ePathology.jpg )

"With one of the most extensive digital pathology initiatives in the world,

Kuwait is leading the charge to transform pathology and its critical role in

healthcare," said Jerome Clavel, Vice President and General Manager for Leica

Biosystems Pathology Imaging. "Our Aperio ePathology Solutions will enable

rapid sharing and collaboration. This will reduce the need for pathologists to

travel and increase patient access especially in remote locations."

The Kuwait Cancer Control Center (KCCC) has been using Aperio ePathology since

2011, for both national and international slide sharing and collaboration.

Building on their experience, the nationwide hub-and-spoke deployment of Aperio

ePathology will enable efficient utilization of Kuwait's pathology expertise;

providing pathologists with rapid access to slides and cases.

"The full adoption of Aperio ePathology throughout Kuwait is a critical,

technological advancement for the pathology workflow. It will make secondary

reviews and collaboration easier, faster and more efficient. In the past,

shipping of glass slides required 3 to 4 days by itself. Now, subspecialty

expertise can be available to remote locations within 24 hours without sending

any physical slides," said Dr. Abdullah Akbar, Consultant Pathologist, Head of

the Laboratory Medicine Department, Sabah Hospital, and Head of the

Histopathology Committee, Ministry of Health. "Digital Pathology will help to

improve turnaround times, and therefore give patients faster results."

*The clinical use claims described in the information provided have not been

cleared or approved by the U.S. FDA nor are the products available in the

United States.

About Leica Biosystems:  

Leica Biosystems (LeicaBiosystems.com) is a global leader in workflow solutions

and automation, integrating each step in the workflow. As the only company to

own the workflow from biopsy to diagnosis, we are uniquely positioned to break

down the barriers between each of these steps. Our mission of "Advancing Cancer

Diagnostics, Improving Lives" is at the heart of our corporate culture. Our

easy-to-use and consistently reliable offerings help improve workflow

efficiency and diagnostic confidence. The company is represented in over 100

countries and is headquartered in Nussloch, Germany.

Media Contact:

Kristin O'Neill

Manager, Global Brand Marketing

LBS-GlobalMarketing@leicabiosystems.com

+1-847-821-3537

Source: Leica Biosystems